ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: APNEIA DO SONO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 16 nov. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 nov. 16 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 nov. 16 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: APNEIA DO SONO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 16 nov. 2024. , 2018
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 16 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.[citado 2024 nov. 16 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Artigo de periodico
The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome (2010)
Drager, Luciano F.; Bortolotto, Luiz A.; Maki-Nunes, Cristiane; Trobetta, Ivani C.; Alves, Maria Janieire N. N.; Fraga, Raffael F.; Negrão, C. E.; Krieger, Eduardo Moacyr; Lorenzi Filho, Geraldo
Source: Atherosclerosis. Unidades: EEFE, FM
Subjects: APNÉIA DO SONO, BIOMARCADORES, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES (METABOLISMO), SÍNDROME X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano F. et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis, v. 208, n. 2, p. 490-495, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2009.08.016. Acesso em: 16 nov. 2024.
APA
Drager, L. F., Bortolotto, L. A., Maki-Nunes, C., Trobetta, I. C., Alves, M. J. N. N., Fraga, R. F., et al. (2010). The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis, 208( 2), 490-495. doi:10.1016/j.atherosclerosis.2009.08.016
NLM
Drager LF, Bortolotto LA, Maki-Nunes C, Trobetta IC, Alves MJNN, Fraga RF, Negrão CE, Krieger EM, Lorenzi Filho G. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome [Internet]. Atherosclerosis. 2010 ; 208( 2): 490-495.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2009.08.016
Vancouver
Drager LF, Bortolotto LA, Maki-Nunes C, Trobetta IC, Alves MJNN, Fraga RF, Negrão CE, Krieger EM, Lorenzi Filho G. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome [Internet]. Atherosclerosis. 2010 ; 208( 2): 490-495.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2009.08.016

USP Schools

ReP

Filtros

Authors

Subjects